2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.46bn
- HK$899.89m
- CNY1.31bn
Annual cashflow statement for Hangzhou Jiuyuan Genetic Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 128 | 51.4 | 135 | 169 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.9 | 11.2 | 23.6 | 26.2 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -95.2 | -75.8 | -58.9 | -137 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 67.5 | 22.6 | 136 | 94.8 | — |
| Capital Expenditures | -62.9 | -59 | -47 | -79.8 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.048 | 0.011 | 0.002 | 0.119 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -62.9 | -58.9 | -47 | -79.7 | — |
| Financing Cash Flow Items | -9.74 | -21 | -14.5 | -46.3 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 41.2 | 12.9 | -67.3 | 428 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 45.8 | -23.3 | 21.6 | 444 | — |